Lublin FD, Miller AE. Multiple sclerosis and other inflammatory demyelinating diseases of the central nervous system. In: Bradley WG, Daroff RB, Fenichel GM, Jankovic J, eds. Bradley: Neurology in Clinical Practice. 5th ed. Philadelphia, Pa: Butterworth-Heinemann Elsevier; 2008:chap 58.
In the United States, we have several non-profit MS-related organizations involved with conducting research, supporting research, or... Read more »
So far I have spent a lot of time reviewing the different medicines available for the treatment of insomnia. Today, we will touch on some... Read more »
Anxiety disorders are treatable, yet only one-third of those diagnosed receive treatment. Often the costs of therapy or prescription drugs... Read more »
New research suggests that the drug Tysabri may regenerate and stabilize damage done to the myelin sheath in people with multiple sclerosis (MS). In... Read more »
The U.S. Food and Drug Administration has approved Risperdal Consta for the treatment of bipolar I disorder. The drug was approved both as a... Read more »
Source: ADAM Encyclopedia
Myelin is an insulating layer that forms around nerves, including those in the brain and spinal cord. It is made up of protein and fatty... Read more »
Source: Harvard Decision Guide
Prevention There is no way to prevent panic disorder. However, if you have been diagnosed with panic disorder, you may be able to prevent panic... Read more »